BAYER HLTHCARE FDA Approval NDA 018714

NDA 018714

BAYER HLTHCARE

FDA Drug Application

Application #018714

Documents

Letter2004-07-21
Label2004-07-21
Label2010-08-01
Label2014-03-05
Letter2004-07-21
Letter2010-08-20
Letter2014-02-27
Label2004-07-21
Label2019-01-09
Letter2019-01-23

Application Sponsors

NDA 018714BAYER HLTHCARE

Marketing Status

Prescription001

Application Products

001TABLET;ORAL600MG1BILTRICIDEPRAZIQUANTEL

FDA Submissions

TYPE 1; Type 1 - New Molecular EntityORIG1AP1982-12-29PRIORITY
LABELING; LabelingSUPPL2AP1985-08-20
LABELING; LabelingSUPPL3AP1988-11-09
MANUF (CMC); Manufacturing (CMC)SUPPL4AP1988-08-09PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1988-08-09PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1989-11-07PRIORITY
LABELING; LabelingSUPPL8AP2004-07-14STANDARD
LABELING; LabelingSUPPL9AP2004-07-14STANDARD
LABELING; LabelingSUPPL12AP2010-08-16STANDARD
LABELING; LabelingSUPPL13AP2014-02-25STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL14AP2014-09-18PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL15AP2014-11-20PRIORITY
LABELING; LabelingSUPPL18AP2019-01-08STANDARD

Submissions Property Types

SUPPL4Null0
SUPPL5Null0
SUPPL6Null0
SUPPL12Null7
SUPPL13Null7
SUPPL14Null0
SUPPL15Null0
SUPPL18Null7

TE Codes

001PrescriptionAB

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 18714
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.